Wedel, H. et al. (2009) Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. European Journal of Heart Failure, 11(3), pp. 281-291. (doi: 10.1093/eurjhf/hfn046)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1093/eurjhf/hfn046
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
Authors: | Wedel, H., McMurray, J., Lindberg, M., Wikstrand, J., Cleland, J., Cornel, J., Dunselman, P., Hjalmarson, A., Kjekshus, J., Komajda, M., Kuusi, T., Vanhaecke, J., and Waagstein, F. |
College/School: | College of Medical Veterinary and Life Sciences College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | European Journal of Heart Failure |
ISSN: | 1388-9842 |
University Staff: Request a correction | Enlighten Editors: Update this record